Advertisement

Topics

USA Insulin Pump Market Users, CGM Continuous Glucose Monitoring Market Users, Reimbursement Policy By States, Diabetes Type1 2 Population, Deal Types, Clinical Trials Forecast [Report Updated: 10082017] Prices from USD $1990

12:56 EDT 18 Aug 2017 | BioPortfolio Report Blog

USA insulin pump market is anticipated to cross US$ 5 Billion by end of the year 2022. Insulin Pump has now become a wellknown and a favored device for Type1 diabetes patients in the United States. The easiness of using insulin pump is gaining comprehensive recognition in the market as insulin delivery systems.


United States CGM Continuous Glucose Monitor Market to be more than US$ 2 Billion in Future

CGM Continuous Glucose Monitor is extremely important across all age groups to manage diabetes efficiently. In the United State, the market of CGM has a huge potential in coming years. From the year 2009 to 2016, Continuous Glucose Monitor users have grown to 35 percent. Many private insurers have started reimbursing CGM based on certain criteria in the United States. Many experts think that CGM is the best tool for diabetes management. For those having several diabetes complications, Continuous Glucose Monitor is very much compatible with that.


In USA by States, Reimbursements of Insulin Pumps, CGM, Diabetes Supplies

According to Renub Research report, we have enclosed many State sponsored programmes, which covers insulin pumps under equipment and supplies. The report also provides reimbursement details on the CGM either by the federal health plan or by the Statesponsored health plan. Nearly every state facilitates diabetes supplies to their city but not all state provides insulin pump. For the stateregulated health insurance policies, all the state law diabetes mandates and least coverage required.


Leading companies Medtronic, Insulet Corporation, Animas Corporation Tandem Diabetes Care Training Model covered in the Report

In this report we have covered, healthcare providers, diabetes educator and certified product trainer etc give inclusive training to new patients. Moreover, via online portal companies also facilitates training to the new pump user to review the training materials. A complete flow chart of training model of all the 4 companies Medtronic, Insulet Corporation, Animas Corporation Tandem Diabetes Care is covered in this report.

Renub Research latest study USA Insulin Pump Market Users, CGM Continuous Glucose Monitoring Market Users, Reimbursement Policy By States, Diabetes Type1 2 Population, Deal Types, Clinical Trials Forecast provides a detailed and comprehensive insight of the Insulin Pump CGM Continuous Glucose Monitoring Market in United States.


Scope of the Report

Insulin Pump Market Forecast: In this report, we have segmented Insulin Pump Market into two part US Type 1 Diabetes Market / Juvenile Diabetes Market and US Type 2 Diabetes Market. Market data from the year 2009 to 2016 and Forecast from the year2017 to the year 2022.

CGM Continuous Glucose Monitor Market Forecast: In this report, the United States CGM market from the year2009 to 2016 and Forecast from the year 2017 to the year 2022.

Reimbursement Policy of USA States: In this report, we have covered the details on USA States reimbursement policy for Insulin Pumps, CGM Continuous Glucose Monitor, Diabetes Supplies Blood Glucose Devices, Test Strips, Lancets, Disposable Needles, Syringe, Ketone Urine Testing Strips, Pen Delivery, Podiatric Appliances, and Oral Agents for controlling blood sugars.

Reimbursement Policy of USA Insurance Companies: In this report, we have covered the reimbursement policy of top 4 insurance companies i.e. Blue Cross and Blue Shield, Aetna, Cigna and United Healthcare for insulin Pumps and CGM Continuous Glucose Monitor.

Training Models: The total 4 companies Medtronic, Insulet Corporation, Animas Corporation Tandem Diabetes Care Training program were covered in the report. Under this segment companies Training program for its staff includes physicians, Certified Diabetes Educators including nurse educators, dietitians and exercise physiologists and support staff with expertise in insulin pump therapy and Training program for patients is being described through flow chart method.

Differentiation Points of Insulin Pump Products: In this topic, we discussed the Advantages and Disadvantages of the following insulin pumps: Animas Vibe, Medtronic 530G with Enlite, Insulet OmniPod, Tandem t:slim, Roche AccuChek Combo.

Major Deal Types: Main global deals of the insulin pump include Collaboration Deals, Manufacturing Agreement, Licensing Agreement, Exclusive Agreement and Partnership Deals are covered in this report.

Clinical Trials of Insulin Pumps: In this Report, we have captured details of clinical trials results for companies on Insulin Pumps. The companies like Medtronic, Insulet Corporation, Tandem Diabetes Care, Roche and Animas Corporation.

Companies Analysis: In this report, we have covered, all the 5 companies from the following points: Overview, Product Details, Insulin Pump Sales Analysis and Latest Development Trends in their insulin pumps. The five companies were as follows: Medtronic, Insulet Corporation, Roche, Animas Corporation Acquired by Johnson Johnson and Tandem Diabetes Care.

Growth Drivers for Insulin Pumps: This topic covers the factors which are helping the Insulin Pump and CGM Continuous Glucose Monitor industry to grow.

Challenges for Insulin Pumps: In this segment, it shows the problems being faced by industry of the Insulin Pump and CGM Continuous Glucose Monitor industry.


Key Companies Covered

1. Medtronic
2. Animas Corporation
3. Insulet Corporation
4. Roche
5. Tandem Diabetes Care

Key Questions Answered in the Report?

What is the Insulin Pump Therapy Market in United States its growth potential in Future?
What is the Continuous Glucose Monitor Market in United States its growth potential in Future?
What is the number of Type 1 and Type 2 Diabetes patients that use insulin pump?
What is the number of CGM patients in United States and its Forecast?
What is the preferred brand of insulin pump in United States?
Is Insulin Pump Therapy Treatment being covered in the Reimbursement policy of United States?
What are the major deals of insulin pump?
What are the latest clinical trials of insulin pump?
What are the key growth drivers and challenges of insulin pump?

Original Article: USA Insulin Pump Market Users, CGM Continuous Glucose Monitoring Market Users, Reimbursement Policy By States, Diabetes Type1 2 Population, Deal Types, Clinical Trials Forecast [Report Updated: 10082017] Prices from USD $1990

NEXT ARTICLE

More From BioPortfolio on "USA Insulin Pump Market Users, CGM Continuous Glucose Monitoring Market Users, Reimbursement Policy By States, Diabetes Type1 2 Population, Deal Types, Clinical Trials Forecast [Report Updated: 10082017] Prices from USD $1990"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...